Adjunctive esketamine in propofol-based sedation for gastrointestinal endoscopy: a systematic review and meta-analysis of randomized trials
Frontiers in Pharmacology · 25.11.2025 · 16
DOI: 10.3389/fphar.2025.1662057 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Pharmacology, online erschienen am 25.11.2025. Verfasst von Jiazheng Qi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Huashan Hospital, Fudan University, Shanghai, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
While propofol is widely used for gastrointestinal endoscopic sedation, its cardiovascular and respiratory side effects and lack of analgesia can compromise safety and comfort. Esketamine provides both sedation and analgesia with minimal hemodynamic or respiratory impact. Combining esketamine with propofol may miti-gate propofol’s adverse effects while enhancing sedation quality. However, the com-bination’s overall safety and efficacy remain inconclusive.
Methods
This systematic review and meta-analysis compared propofol-based sedation with versus without intravenous esketamine in gastrointestinal endoscopy, synthesizing evidence from randomized controlled trials. The primary outcome was the incidence of hypotension. Secondary outcomes included intraoperative adverse respiratory events, propofol consumption, involuntary movement, hypertension, arrhythmias, PONV recovery times, and dizziness.
Results
Eighteen trials were included in the analysis. Additional esketamine significantly reduced the incidence of hypotension (risk ratio [RR]: 0.32; 95% confidence interval [CI]: 0.24 to 0.43; P < 0.01; I 2 = 44.4%; moderate quality). The addition of esketamine to propofol can reduce the incidence of adverse respiratory events (RR: 0.57, 95% CI: 0.38 to 0.86; P < 0.01; I 2 = 67.8%; moderate quality). Esketamine added to propofol decreased involuntary movement (RR: 0.61, 95% CI: 0.42 to 0.92; P = 0.02; I 2 = 77.2%; low quality) and reduced the propofol consumption (mean difference [MD]: −0.94, 95% CI: −1.53 to −0.35 mg/kg; P < 0.01; I 2 = 96.2%; low quality). No significant differences were found for hypertension, arrhythmias, PONV, recovery time or dizziness.
Conclusion
Supplementing propofol-based sedation with esketamine reduced the risk of hypotension and adverse respiratory events, without increasing cardiovascular complications, or extending recovery-time. Systematic Review Registration https://www.crd.york.ac.uk/PROSPERO/ , identifier CRD420251030940.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesiology, Huashan Hospital, Fudan University, Shanghai, China.
- Department of Anesthesiology, Second Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang, China.
- Department of Anesthesiology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Zitieren
APA
Qi, J., Luo, M., Zong, W., Zhang, L., Chen, B., Yang, X., Xu, B., & Zhao, X. (2025). Adjunctive esketamine in propofol-based sedation for gastrointestinal endoscopy: a systematic review and meta-analysis of randomized trials. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1662057
Vancouver
Qi J, Luo M, Zong W, Zhang L, Chen B, Yang X, et al. Adjunctive esketamine in propofol-based sedation for gastrointestinal endoscopy: a systematic review and meta-analysis of randomized trials. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1662057
BibTeX
@article{Qi2025,
author = {Qi, Jiazheng and Luo, Mengqiang and Zong, Wenru and Zhang, Lingjing and Chen, Baoxuan and Yang, Xiaoyu and Xu, Bo and Zhao, Xu},
title = {Adjunctive esketamine in propofol-based sedation for gastrointestinal endoscopy: a systematic review and meta-analysis of randomized trials},
journal = {Frontiers in Pharmacology},
year = {2025},
volume = {16},
doi = {10.3389/fphar.2025.1662057}
}
EUVIMED